SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001095435-16-000051
Filing Date
2016-05-26
Accepted
2016-05-26 16:40:23
Documents
1
Period of Report
2016-05-26

Document Format Files

Seq Description Document Type Size
1 PORTAGE ANNOUNCES ORPHAN DRUG DESIGNATION REQUEST GRANTED FTO BIOHAVEN FOR BHV 4 pr52615.htm 6-K 25612
  Complete submission text file 0001095435-16-000051.txt   26806
Mailing Address 47 AVENUE ROAD SUITE 200 TORONTO A6 M5R 2G3
Business Address 47 AVENUE ROAD SUITE 200 TORONTO A6 M5R 2G3 416-929-1806
PORTAGE BIOTECH INC. (Filer) CIK: 0001095435 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 000-30314 | Film No.: 161678683
SIC: 1311 Crude Petroleum & Natural Gas